Molecular Diagnosis of Ataxias and Spastic Paraplegias
T. Gasser
University of Tübingen, and German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
Search for more papers by this authorJ. Finsterer
Rudolfstiftung and Danube University, Krems, Vienna, Austria
Search for more papers by this authorJ. Baets
University Hospital of Antwerp, Antwerpen, Belgium
VIB, Antwerpen, Belgium
Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
Search for more papers by this authorC. Van Broeckhoven
VIB, Antwerpen, Belgium
Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
Search for more papers by this authorS. Di Donato
Fondazione-IRCCS, Istituto Neurologico Carlo Besta, Milan, Italy
Search for more papers by this authorB. Fontaine
Assistance Publique-Hôpitaux de Paris, Centre de référence des canalopathies musculaires, Groupe Hospitalier, Pitié-Salpêtrière, Paris, France
Search for more papers by this authorP. De Jonghe
University Hospital of Antwerp, Antwerpen, Belgium
VIB, Antwerpen, Belgium
Search for more papers by this authorT. Lynch
Mater Misericordiae University, Beaumont & Mater Private Hospitals, Dublin, Ireland
Search for more papers by this authorC. Mariotti
IRCCS Foundation, Neurological Institute Carlo Besta, Milan, Italy
Search for more papers by this authorL. Schöls
University of Tübingen, and German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
Search for more papers by this authorA. Spinazzola
IRCCS Foundation, Neurological Institute Carlo Besta, Milan, Italy
Search for more papers by this authorZ. Szolnoki
IRCCS Foundation, Neurological Institute Carlo Besta, Milan, Italy
Search for more papers by this authorS. J. Tabrizi
Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
Search for more papers by this authorC. M. E. Tallaksen
Oslo University Hospital, and Faculty of Medicine, University of Oslo, Oslo, Norway
Search for more papers by this authorM. Zeviani
IRCCS Foundation, Neurological Institute Carlo Besta, Milan, Italy
Search for more papers by this authorH. F. Harbo
Oslo University Hospital, and Faculty of Medicine, University of Oslo, Oslo, Norway
Search for more papers by this authorT. Gasser
University of Tübingen, and German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
Search for more papers by this authorJ. Finsterer
Rudolfstiftung and Danube University, Krems, Vienna, Austria
Search for more papers by this authorJ. Baets
University Hospital of Antwerp, Antwerpen, Belgium
VIB, Antwerpen, Belgium
Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
Search for more papers by this authorC. Van Broeckhoven
VIB, Antwerpen, Belgium
Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
Search for more papers by this authorS. Di Donato
Fondazione-IRCCS, Istituto Neurologico Carlo Besta, Milan, Italy
Search for more papers by this authorB. Fontaine
Assistance Publique-Hôpitaux de Paris, Centre de référence des canalopathies musculaires, Groupe Hospitalier, Pitié-Salpêtrière, Paris, France
Search for more papers by this authorP. De Jonghe
University Hospital of Antwerp, Antwerpen, Belgium
VIB, Antwerpen, Belgium
Search for more papers by this authorT. Lynch
Mater Misericordiae University, Beaumont & Mater Private Hospitals, Dublin, Ireland
Search for more papers by this authorC. Mariotti
IRCCS Foundation, Neurological Institute Carlo Besta, Milan, Italy
Search for more papers by this authorL. Schöls
University of Tübingen, and German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
Search for more papers by this authorA. Spinazzola
IRCCS Foundation, Neurological Institute Carlo Besta, Milan, Italy
Search for more papers by this authorZ. Szolnoki
IRCCS Foundation, Neurological Institute Carlo Besta, Milan, Italy
Search for more papers by this authorS. J. Tabrizi
Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
Search for more papers by this authorC. M. E. Tallaksen
Oslo University Hospital, and Faculty of Medicine, University of Oslo, Oslo, Norway
Search for more papers by this authorM. Zeviani
IRCCS Foundation, Neurological Institute Carlo Besta, Milan, Italy
Search for more papers by this authorH. F. Harbo
Oslo University Hospital, and Faculty of Medicine, University of Oslo, Oslo, Norway
Search for more papers by this authorNils Erik Gilhus MD, PHD
Department of Clinical Medicine, University of Bergen, Norway
Department of Neurology, Haukeland University Hospital, Bergen, Norway
Search for more papers by this authorMichael P. Barnes MD, FRCP
University of Newcastle, Newcastle upon Tyne, UK
Hunters Moor Neurorehabilitation Ltd, Newcastle upon Tyne, UK
Search for more papers by this authorMichael Brainin MD
Department of Clinical Medicine and Prevention, Austria
Center for Clinical Neurosciences, Donau-Universität Krems, Austria
Department of Neurology, Landesklinikum Donauregion Tulln, Tulln, Austria
Search for more papers by this authorSummary
The molecular basis of an increasing number of inherited neurological diseases has been elucidated during recent years, and molecular diagnosis of these disorders is becoming a matter of clinical practice. This progress has been particularly evident in the field of the hereditary ataxias and spastic paraplegias. The EFNS guidelines attempt to provide practical help for the clinical neurologist to make appropriate use of the possibilities of molecular testing in these two complex groups of disorders. The guidelines summarize the possibilities and limitations of molecular genetic diagnosis and discuss practical issues, such as diagnostic criteria, to inform the decision whether or not a molecular diagnostic work-up should be initiated.
References
- Gasser T, Dichgans M, Finsterer J, et al. EFNS Task Force on Molecular Diagnosis of Neurologic Disorders: guidelines for the molecular diagnosis of inherited neurologic diseases. Second of two parts. Eur J Neurol 2001; 8: 407–24.
- Gasser T, Dichgans M, Finsterer J, et al. EFNS Task Force on Molecular Diagnosis of Neurologic Disorders: guidelines for the molecular diagnosis of inherited neurologic diseases. First of two parts. Eur J Neurol 2001; 8: 299–314.
- Brainin M, Barnes M, Baron JC, et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces–revised recommendation. 2004. Eur J Neurol 2004; 11: 577–81.
- Fogel BL, Perlman S. Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. Lancet Neurol 2007; 6: 245–57.
- Soong BW, Paulson HL. Spinocerebellar ataxias: an update. Curr Opin Neurol 2007; 20: 438–46.
- Storey E, Bahlo M, Fahey M, et al. A new dominantly inherited pure cerebellar ataxia, SCA30. J Neurol Neurosurg Psychiatry 2009; 80: 408–11.
- Koide R, Ikeuchi T, Onodera O, et al. Unstable expansion of CAG repeat in hereditary dentatorubral–pallidoluysian atrophy (DRPLA). Nat Genet 1994; 6: 9–13.
- Hellenbroich Y, Bernard V, Zühlke C. Spinocerebellar ataxia type 4 and 16q–linked Japanese ataxia are not allelic. J Neurol 2008; 255: 612–13.
- Schelhaas HJ, Verbeek DS, Van de Warrenburg BPC, Sinke RJ. SCA19 and SCA22: evidence for one locus with a worldwide distribution. Brain 2004; 127: e6.
- Moseley ML, Benzow KA, Schut LJ, et al. Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families. Neurology 1998; 51: 1666–71.
- Silveira I, Miranda C, Guimarães L, et al. Trinucleotide repeats in 202 families with ataxia: a small expanded (CAG) n allele at the SCA17 locus. Arch Neurol 2002; 59: 623–9.
- Brusco A, Gellera C, Cagnoli C et al. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of SCA genes and CAG/CTG repeat expansion detection (RED) in 225 Italian families. Arch Neurol 2004; 61: 727–73.
- Jen JC. Recent advances in the genetics of recurrent vertigo and vestibulopathy. Curr Opin Neurol 2008; 21: 3–7.
- Jen JC, Graves TD, Hess EJ, et al. Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain 2007; 130: 2484–93.
- Pandolfo M. Friedreich ataxia. Semin Pediatr Neurol 2003; 10: 163–72.
- Le Ber, I, Brice A, Durr A. New autosomal recessive cerebellar ataxias with oculomotor apraxia. Curr Neurol Neurosci Rep 2005; 5: 411–17.
- Taylor AM, Byrd PJ. Molecular pathology of ataxia telangiectasia. J Clin Pathol 2005; 58: 1009–15.
- Cavalier L, Ouahchi K, Kayden HJ, et al. Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families. Am J Hum Genet 1998; 62: 301–10.
- Berry-Kravis E, Abrams L, Coffey SM, et al. Fragile X–associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. Mov Disord 2007; 22: 2018–30.
- Fink JK. Hereditary spastic paraplegia. Curr Neurol Neurosci Rep 2006; 6: 65–76.
- Stevanin G, Ruberg M, Brice A. Recent advances in the genetics of spastic paraplegias. Curr Neurol Neurosci Rep 2008; 8: 198–210.
- Woodward KJ. The molecular and cellular defects underlying Pelizaeus–Merzbacher disease. Expert Reviews in Molecular Medicine 2008; 10: e14.
- Patrono C, Scarano V, Cricchi F, et al. Autosomal dominant hereditary spastic paraplegia: DHPLC–based mutation analysis of SPG4 reveals eleven novel mutations. Hum Mutat 2005; 25. 506.
- Beetz C, Nygren AO, Schickel J, et al. High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology 2006; 67: 1926–30.
- Durr A, Camuzat A, Colin E, et al. Atlastin1 mutations are frequent in young–onset autosomal dominant spastic paraplegia. Arch Neurol 2004; 61: 1867–72.
- Beetz C, Schule R, Deconinck T, et al. REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia typ. 31. Brain 2008; 131: 1078–86.
- Schule R, Kremer BP, Kassubek J, et al. SPG10 is a rare cause of spastic paraplegia in European families. J Neurol Neurosurg Psychiatry 2008; 79: 584–7.
- Mannan AU, Krawen P, Sauter SM, et al. ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia. Am J Hum Genet 2006; 79: 351–7.
- Brugman F, Scheffer H, Wokke JH, et al. Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes. Neurology 2008; 71: 1500–5.
- Stevanin G, Azzedine H, Denora P, et al. Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain 2008; 131: 772–84.
- Hanein S, Martin E, Boukhris A, et al. Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal–recessive spastic paraplegia, including Kjellin syndrome. Am J Hum Genet 2008; 82: 992–1002.
- Vermeer S, Meijer RP, Pijl BJ, et al. ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia. Neurogenetics 2008; 9: 207–14.
- Depienne C, Tallaksen C, Lephay JY, et al. Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. J Med Genet 2006; 43: 259–65.
- Martignoni M, Riano E, Rugarli EI. The role of ZFYVE27/ protrudin in hereditary spastic paraplegia. Am J Hum Genet 2008; 83: 127–8.